"Your health is our #1 Priority. Medvin Clinical Research is a multi-specialty, multi-facility Research Company based in Los Angeles, California that has been conducting clinical trials in Rheumatology, Gastroenterology, Cardiology and Internal medicine among other indications since 2006. We have successfully completed in excess of 130 trials and helped over a 3000 patients achieve the quality of life that they deserve."

During the past decade, Medvin Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medvin Clinical Research" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Horizon Therapeutics Ireland DAC" with 2 trials sponsored, "Anika Therapeutics, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medvin Clinical Research" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Medvin Clinical Research" are "Gout" (3 trials), "Rheumatoid Arthritis" (2 trials), "Active Psoriatic Arthritis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Medvin Clinical Research" in a lesser frequency.

Most popular intervention types in "Medvin Clinical Research" are "Drug" (8 trials), "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BMS-986165 Dose A" (1 trials), "BMS-986165 Dose B" (1 trials), "BMS-986165 Placebo" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medvin Clinical Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Medvin Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Medvin Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medvin Clinical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".